These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 30509945

  • 1. Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.
    Tran TT, Mishra NN, Seepersaud R, Diaz L, Rios R, Dinh AQ, Garcia-de-la-Maria C, Rybak MJ, Miro JM, Shelburne SA, Sullam PM, Bayer AS, Arias CA.
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509945
    [Abstract] [Full Text] [Related]

  • 2. Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
    Adams HM, Joyce LR, Guan Z, Akins RL, Palmer KL.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223392
    [Abstract] [Full Text] [Related]

  • 3. Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.
    Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Proctor R, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115347
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Kebriaei R, Rice SA, Stamper KC, Seepersaud R, Garcia-de-la-Maria C, Mishra NN, Miro JM, Arias CA, Tran TT, Sullam PM, Bayer AS, Rybak MJ.
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance.
    Mishra NN, Abdelhady W, Elsayed AM, Lapitan C, Proctor RA, Rybak MJ, Miro JM, Bayer AS.
    Antimicrob Agents Chemother; 2023 Apr 18; 67(4):e0147222. PubMed ID: 36877026
    [Abstract] [Full Text] [Related]

  • 9. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2013 May 18; 57(5):2319-25. PubMed ID: 23478959
    [Abstract] [Full Text] [Related]

  • 10. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.
    Antimicrob Agents Chemother; 2017 May 18; 61(5):. PubMed ID: 28264848
    [Abstract] [Full Text] [Related]

  • 11. Streptococcus pneumoniae, S. mitis, and S. oralis Produce a Phosphatidylglycerol-Dependent, ltaS-Independent Glycerophosphate-Linked Glycolipid.
    Wei Y, Joyce LR, Wall AM, Guan Z, Palmer KL.
    mSphere; 2021 Feb 24; 6(1):. PubMed ID: 33627509
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.
    Teles C, Smith A, Lang S.
    Antimicrob Agents Chemother; 2012 Jan 24; 56(1):458-63. PubMed ID: 22037854
    [Abstract] [Full Text] [Related]

  • 20. Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in Streptococcus pneumoniae, S. mitis and S. oralis.
    Chi F, Nolte O, Bergmann C, Ip M, Hakenbeck R.
    Int J Med Microbiol; 2007 Nov 24; 297(7-8):503-12. PubMed ID: 17459765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.